Paper22720237
Tgf-β1 produced by activated CD4(+) T Cells Antagonizes T Cell Surveillance of Tumor Development.
Donkor MK and 2 others. Oncoimmunology, 2012. Cited by 42 papers, by iCite.
Cite this record
ConductScience Library. Tgf-β1 produced by activated CD4(+) T Cells Antagonizes T Cell Surveillance of Tumor Development. Papers, record 22720237. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22720237
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Tgf-β1 produced by activated CD4(+) T Cells Antagonizes T Cell Surveillance of Tumor Development.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12482908 | Making sense of latent TGFbeta activation. | J Cell Sci | 2003 | https://conductscience.org/library/papers/12482908 | PubMed |
| 2 | 18026089 | Adaptive immunity maintains occult cancer in an equilibrium state. | Nature | 2007 | https://conductscience.org/library/papers/18026089 | PubMed |
| 3 | 18173375 | PD-1 and its ligands in tolerance and immunity. | Annu Rev Immunol | 2008 | https://conductscience.org/library/papers/18173375 | PubMed |
| 4 | 1436033 | Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. | Nature | 1992 | https://conductscience.org/library/papers/1436033 | PubMed |
| 5 | 17481928 | T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation. | Immunity | 2007 | https://conductscience.org/library/papers/17481928 | PubMed |
| 6 | 12093877 | Suppression of lymphoma and epithelial malignancies effected by interferon gamma. | J Exp Med | 2002 | https://conductscience.org/library/papers/12093877 | PubMed |
| 7 | 16973386 | Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. | Immunity | 2006 | https://conductscience.org/library/papers/16973386 | PubMed |
| 8 | 16973387 | Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-beta receptor. | Immunity | 2006 | https://conductscience.org/library/papers/16973387 | PubMed |
| 9 | 11590434 | Immune-mediated eradication of tumors through the blockade of transforming growth factor-beta signaling in T cells. | Nat Med | 2001 | https://conductscience.org/library/papers/11590434 | PubMed |
| 10 | 4921480 | The concept of immunological surveillance. | Prog Exp Tumor Res | 1970 | https://conductscience.org/library/papers/4921480 | PubMed |
| 11 | 18684640 | Specificity in cancer immunotherapy. | Semin Immunol | 2008 | https://conductscience.org/library/papers/18684640 | PubMed |
| 12 | 18692464 | TGF-beta: a master of all T cell trades. | Cell | 2008 | https://conductscience.org/library/papers/18692464 | PubMed |
| 13 | 194247 | Immune surveillance against virus-induced tumors and nonrejectability of spontaneous tumors: contrasting consequences of host versus tumor evolution. | Proc Natl Acad Sci U S A | 1977 | https://conductscience.org/library/papers/194247 | PubMed |
| 14 | 16286245 | TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance. | Cancer Cell | 2005 | https://conductscience.org/library/papers/16286245 | PubMed |
| 15 | 11323675 | IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. | Nature | 2001 | https://conductscience.org/library/papers/11323675 | PubMed |
| 16 | 17895374 | Ulcerative colitis and autoimmunity induced by loss of myeloid alphav integrins. | Proc Natl Acad Sci U S A | 2007 | https://conductscience.org/library/papers/17895374 | PubMed |
| 17 | 21757379 | T cell surveillance of oncogene-induced prostate cancer is impeded by T cell-derived TGF-β1 cytokine. | Immunity | 2011 | https://conductscience.org/library/papers/21757379 | PubMed |
| 18 | 15753372 | Adoptive transfer of tumor-reactive transforming growth factor-beta-insensitive CD8+ T cells: eradication of autologous mouse prostate cancer. | Cancer Res | 2005 | https://conductscience.org/library/papers/15753372 | PubMed |
| 19 | 17312132 | Tumor evasion of the immune system by converting CD4+CD25- T cells into CD4+CD25+ T regulatory cells: role of tumor-derived TGF-beta. | J Immunol | 2007 | https://conductscience.org/library/papers/17312132 | PubMed |
| 20 | 8811491 | Modulation of B16 melanoma growth and metastasis by anti-transforming growth factor beta antibody and interleukin-2. | J Immunother Emphasis Tumor Immunol | 1996 | https://conductscience.org/library/papers/8811491 | PubMed |
Cited by28
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40787250 | Identification of immune escape-related prognostic genes and immune infiltration analysis in hepatocellular carcinoma based on bioinformatics. | Biochem Biophys Rep | 2025 | https://conductscience.org/library/papers/40787250 | PubMed |
| 38514615 | TGF-β signaling in health, disease, and therapeutics. | Signal Transduct Target Ther | 2024 | https://conductscience.org/library/papers/38514615 | PubMed |
| 38376927 | Potentiating the radiation-induced type I interferon antitumoral immune response by ATM inhibition in pancreatic cancer. | JCI Insight | 2024 | https://conductscience.org/library/papers/38376927 | PubMed |
| 36650384 | Molecular and therapeutic effect of CRISPR in treating cancer. | Med Oncol | 2023 | https://conductscience.org/library/papers/36650384 | PubMed |
| 36417079 | Progress in the relationship between P2X7R and colorectal cancer. | Mol Biol Rep | 2023 | https://conductscience.org/library/papers/36417079 | PubMed |
| 36382146 | TGFβ: Signaling Blockade for Cancer Immunotherapy. | Annu Rev Cancer Biol | 2022 | https://conductscience.org/library/papers/36382146 | PubMed |
| 36380023 | TGFβ control of immune responses in cancer: a holistic immuno-oncology perspective. | Nat Rev Immunol | 2023 | https://conductscience.org/library/papers/36380023 | PubMed |
| 36326892 | Immunotherapy for lung cancer combining the oligodeoxynucleotides of TLR9 agonist and TGF-β2 inhibitor. | Cancer Immunol Immunother | 2023 | https://conductscience.org/library/papers/36326892 | PubMed |
| 36229613 | TGF-β-dependent lymphoid tissue residency of stem-like T cells limits response to tumor vaccine. | Nat Commun | 2022 | https://conductscience.org/library/papers/36229613 | PubMed |
| 36072935 | The systemic-level repercussions of cancer-associated inflammation mediators produced in the tumor microenvironment. | Front Endocrinol (Lausanne) | 2022 | https://conductscience.org/library/papers/36072935 | PubMed |
| 36003368 | Metabolic rewiring directs melanoma immunology. | Front Immunol | 2022 | https://conductscience.org/library/papers/36003368 | PubMed |
| 34834295 | Circulating Tumour Cells (CTCs) in NSCLC: From Prognosis to Therapy Design. | Pharmaceutics | 2021 | https://conductscience.org/library/papers/34834295 | PubMed |
| 34780568 | The differentiation state of the Schwann cell progenitor drives phenotypic variation between two contagious cancers. | PLoS Pathog | 2021 | https://conductscience.org/library/papers/34780568 | PubMed |
| 34305041 | Immunity beyond cancer cells: perspective from tumor tissue. | Trends Cancer | 2021 | https://conductscience.org/library/papers/34305041 | PubMed |
| 33974997 | Self-driving armored CAR-T cells overcome a suppressive milieu and eradicate CD19+ Raji lymphoma in preclinical models. | Mol Ther | 2021 | https://conductscience.org/library/papers/33974997 | PubMed |
| 33828560 | Frequency of Effector Memory Cells Expressing Integrin α4β7 Is Associated With TGF-β1 Levels in Therapy Naïve HIV Infected Women With Low CD4+ T Cell Count. | Front Immunol | 2021 | https://conductscience.org/library/papers/33828560 | PubMed |
| 33771888 | A tumor-specific mechanism of Treg enrichment mediated by the integrin αvβ8. | Sci Immunol | 2021 | https://conductscience.org/library/papers/33771888 | PubMed |
| 33717139 | The Impact of Tregs on the Anticancer Immunity and the Efficacy of Immune Checkpoint Inhibitor Therapies. | Front Immunol | 2021 | https://conductscience.org/library/papers/33717139 | PubMed |
| 33087928 | TGF-β suppresses type 2 immunity to cancer. | Nature | 2020 | https://conductscience.org/library/papers/33087928 | PubMed |
| 32710082 | TGFβ biology in cancer progression and immunotherapy. | Nat Rev Clin Oncol | 2021 | https://conductscience.org/library/papers/32710082 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| IFNG | 3458 | PubTator's text mining | https://conductscience.org/library/genes/3458 | NCBI Gene |
| TGFB1 | 7040 | PubTator's text mining | https://conductscience.org/library/genes/7040 | NCBI Gene |
| TGFBR2 | 7048 | PubTator's text mining | https://conductscience.org/library/genes/7048 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22720237
GET https://conductscience.org/api/papers/v1/22720237/references?page=2